• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA22-90/I16-30
Medical Device Problem Code Device Stenosis (4066)
Health Effect - Clinical Code Stenosis (2263)
Date of Event 03/26/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2.
 
Event or Problem Description
The patient was initially implanted with an afx2 bifurcated stent graft (bsg) and an afx vela suprarenal aortic extension to treat an abdominal aortic aneurysm (aaa) on (b)(6) 2025.There was a slight type ia endoleak observed on angiography, so a proximal touch-up was performed.After the subsequent angiography confirmed the disappearance of the type i endoleak, the procedure was completed.It was reported that the patient's ankle brachial index, (abi) was 1.13/1.16 preoperatively, but a pressure gradient was observed postoperatively and had an abi of 1.12/0.72.The physician elected to implant an express vascular ld 8mm-27mm (non-endologix) stent in the left common iliac artery on (b)(6) 2025 after which the pressure gradient improved.The patient status was not reported.
 
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Per communication with jll (distributor) all information for the evaluation of this event that is available has been provided.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix the type ia endoleak (resolved) is unconfirmed.The main body left limb stenosis and additional endovascular procedure are confirmed.This is moderately consistent with the reported adverse event/incident.Device, user, procedure or anatomy relatedness of complaint could not be determined.Procedure related harms could not be determined.The aortic neck length was 13 mm (should be greater than 15mm).It is unlikely that this off label condition contributed to the stenosis of the iliac limb.The final patient status was not reported.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Common Device Name
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer Contact
gary kirchgater
2 musick
irvine, CA 92618
8009832284
MDR Report Key21901989
Report Number3011063223-2025-00053
Device Sequence Number12960519
Product Code MIH
UDI-Device Identifier00818009015136
UDI-Public(01)00818009015136(17)270307
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/27/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberBEA22-90/I16-30
Device Lot Number2774301005
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/27/2025
Supplement Date Received by Manufacturer05/01/2025
Initial Report FDA Received Date04/24/2025
Supplement Report FDA Received Date06/20/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/28/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
VELA SUPRARENAL EXTENSION: LOT # 2761444001.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-